Redx Pharma Limited
Records under this name other than the patents Redx Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,102,656 | Use of rosuvastatin lactols as medicaments Formerly held Lapsed on the fee record Ended Aug 11, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 11, 2019 | From the USPTO record |
| US 9,024,025 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended May 5, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 5, 2019 | From the USPTO record |
| US 9,006,282 | Rosuvastatin and atorvastatin derivatives Formerly held Lapsed on the fee record Ended Apr 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2019 | From the USPTO record |
| US 8,946,224 | Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions Formerly held Lapsed on the fee record Ended Feb 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2019 | From the USPTO record |
| US 8,877,945 | Redox drug derivatives Formerly held Lapsed on the fee record Ended Nov 4, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 4, 2018 | From the USPTO record |
| US 8,853,429 | Process and intermediate compounds useful in the preparation of statins Formerly held Lapsed on the fee record Ended Oct 7, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2018 | From the USPTO record |
| US 8,703,945 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended Apr 22, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2018 | From the USPTO record |
| US 8,614,335 | Process and intermediates useful in the preparation of statins, particularly atorvastatin Formerly held Lapsed on the fee record Ended Dec 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 24, 2017 | From the USPTO record |
| US 8,519,164 | Process and intermediate compounds useful in the preparation of statins Formerly held Lapsed on the fee record Ended Aug 27, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2017 | From the USPTO record |
| US 8,513,412 | Rosuvastatin and atorvastatin derivatives Formerly held Lapsed on the fee record Ended Aug 20, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2017 | From the USPTO record |